Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| N-[[5-[1-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]benzamide | IC50 | 21000.0 [1], 100000.0 [2] | |
| N-[[5-[2-(2-Imidazol-1-ylethyl)indazol-3-yl]-1,2,4-oxadiazol-3-yl]methyl]-3-(trifluoromethoxy)benzamide | IC50 | 2550.0 [1], 8540.0 [2], 15300.0 [3] | |
| 6-(4-(Trifluoromethoxy)phenyl)-3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridine | IC50 | 400.0 [1], 10000.0 [2] | |
| 2,2-Diphenyl-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamide | IC50 | 20.0 [1], 32.0 [2] | |
| 2-[(3-Methyl-1,2,4-oxadiazol-5-yl)methyl]-6-[4-(trifluoromethoxy)phenyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one | IC50 | 4800.0 [1], 10000.0 [2] | |
MLA | "Quest Database™ Sodium channel protein type I alpha subunit Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 5 Nov. 2025, https://www.aatbio.com/data-sets/sodium-channel-protein-type-i-alpha-subunit-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, November 5). Quest Database™ Sodium channel protein type I alpha subunit Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/sodium-channel-protein-type-i-alpha-subunit-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |